カルレティキュリン (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "カルレティキュリン" in Japanese language version.

refsWebsite

Global rank Japanese rank

4^th place

24^th place

2^nd place

6^th place

5^th place

19^th place

1,626^th place

2,625^th place

low place

low place

1web.archive.org

1^st place

1^st place

179^th place

608^th place

doi.org

“A human Ro/SS-A autoantigen is the homologue of calreticulin and is highly homologous with onchocercal RAL-1 antigen and an aplysia "memory molecule"”. The Journal of Clinical Investigation 86 (1): 332–5. (Jul 1990). doi:10.1172/JCI114704. PMC 296725. PMID 2365822.
Kozlov, Guennadi; Gehring, Kalle (2020-10). “Calnexin cycle - structural features of the ER chaperone system”. The FEBS journal 287 (20): 4322–4340. doi:10.1111/febs.15330. ISSN 1742-4658. PMC 7687155. PMID 32285592.
“Calreticulin in cardiac development and pathology”. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1600 (1–2): 32–7. (Nov 2002). doi:10.1016/S1570-9639(02)00441-7. PMID 12445456.
Burns, K.; Duggan, B.; Atkinson, E. A.; Famulski, K. S.; Nemer, M.; Bleackley, R. C.; Michalak, M. (1994-02-03). “Modulation of gene expression by calreticulin binding to the glucocorticoid receptor”. Nature 367 (6462): 476–480. doi:10.1038/367476a0. ISSN 0028-0836. PMID 8107808.
Dedhar, S.; Rennie, P. S.; Shago, M.; Hagesteijn, C. Y.; Yang, H.; Filmus, J.; Hawley, R. G.; Bruchovsky, N. et al. (1994-02-03). “Inhibition of nuclear hormone receptor activity by calreticulin”. Nature 367 (6462): 480–483. doi:10.1038/367480a0. ISSN 0028-0836. PMID 8107809.
Orth, T.; Dorner, T.; Meyer Zum Buschenfelde, K. H.; Mayet, W. J. (1996-03). “Complete congenital heart block is associated with increased autoantibody titers against calreticulin”. European Journal of Clinical Investigation 26 (3): 205–215. doi:10.1046/j.1365-2362.1996.120270.x. ISSN 0014-2972. PMID 8904349.
“Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2”. The New England Journal of Medicine 369 (25): 2391–405. (Dec 2013). doi:10.1056/NEJMoa1312542. PMC 3966280. PMID 24325359.
“Somatic mutations of calreticulin in myeloproliferative neoplasms”. The New England Journal of Medicine 369 (25): 2379–90. (Dec 2013). doi:10.1056/NEJMoa1311347. PMID 24325356.
“Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47”. Science Translational Medicine 2 (63): 63ra94. (Dec 2010). doi:10.1126/scitranslmed.3001375. PMC 4126904. PMID 21178137.
- Christopher Vaughan (December 22, 2010). “Many cancer cells found to have an 'eat me' signal in study”. Stanford School of Medicine. 2013年10月16日時点のオリジナルよりアーカイブ。2023年1月29日
- “Interaction between a Ca2+-binding protein calreticulin and perforin, a component of the cytotoxic T-cell granules”. Biochemistry 37 (29): 10386–94. (Jul 1998). doi:10.1021/bi980595z. PMID 9671507.
- “Calreticulin enhances the transcriptional activity of thyroid transcription factor-1 by binding to its homeodomain”. The Journal of Biological Chemistry 274 (8): 4640–5. (Feb 1999). doi:10.1074/jbc.274.8.4640. PMID 9988700.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000179218 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000003814 - Ensembl, May 2017

nih.gov

pubmed.ncbi.nlm.nih.gov

“A human Ro/SS-A autoantigen is the homologue of calreticulin and is highly homologous with onchocercal RAL-1 antigen and an aplysia "memory molecule"”. The Journal of Clinical Investigation 86 (1): 332–5. (Jul 1990). doi:10.1172/JCI114704. PMC 296725. PMID 2365822.
“HLA-H and associated proteins in patients with hemochromatosis”. Molecular Medicine (Cambridge, Mass.) 3 (6): 397–402. (June 1997). PMC 2230203. PMID 9234244.
Kozlov, Guennadi; Gehring, Kalle (2020-10). “Calnexin cycle - structural features of the ER chaperone system”. The FEBS journal 287 (20): 4322–4340. doi:10.1111/febs.15330. ISSN 1742-4658. PMC 7687155. PMID 32285592.
“Calreticulin in cardiac development and pathology”. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1600 (1–2): 32–7. (Nov 2002). doi:10.1016/S1570-9639(02)00441-7. PMID 12445456.
Burns, K.; Duggan, B.; Atkinson, E. A.; Famulski, K. S.; Nemer, M.; Bleackley, R. C.; Michalak, M. (1994-02-03). “Modulation of gene expression by calreticulin binding to the glucocorticoid receptor”. Nature 367 (6462): 476–480. doi:10.1038/367476a0. ISSN 0028-0836. PMID 8107808.
Dedhar, S.; Rennie, P. S.; Shago, M.; Hagesteijn, C. Y.; Yang, H.; Filmus, J.; Hawley, R. G.; Bruchovsky, N. et al. (1994-02-03). “Inhibition of nuclear hormone receptor activity by calreticulin”. Nature 367 (6462): 480–483. doi:10.1038/367480a0. ISSN 0028-0836. PMID 8107809.
Orth, T.; Dorner, T.; Meyer Zum Buschenfelde, K. H.; Mayet, W. J. (1996-03). “Complete congenital heart block is associated with increased autoantibody titers against calreticulin”. European Journal of Clinical Investigation 26 (3): 205–215. doi:10.1046/j.1365-2362.1996.120270.x. ISSN 0014-2972. PMID 8904349.
“Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2”. The New England Journal of Medicine 369 (25): 2391–405. (Dec 2013). doi:10.1056/NEJMoa1312542. PMC 3966280. PMID 24325359.
“Somatic mutations of calreticulin in myeloproliferative neoplasms”. The New England Journal of Medicine 369 (25): 2379–90. (Dec 2013). doi:10.1056/NEJMoa1311347. PMID 24325356.
“Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47”. Science Translational Medicine 2 (63): 63ra94. (Dec 2010). doi:10.1126/scitranslmed.3001375. PMC 4126904. PMID 21178137.
- Christopher Vaughan (December 22, 2010). “Many cancer cells found to have an 'eat me' signal in study”. Stanford School of Medicine. 2013年10月16日時点のオリジナルよりアーカイブ。2023年1月29日
- “Interaction between a Ca2+-binding protein calreticulin and perforin, a component of the cytotoxic T-cell granules”. Biochemistry 37 (29): 10386–94. (Jul 1998). doi:10.1021/bi980595z. PMID 9671507.
- “Calreticulin enhances the transcriptional activity of thyroid transcription factor-1 by binding to its homeodomain”. The Journal of Biological Chemistry 274 (8): 4640–5. (Feb 1999). doi:10.1074/jbc.274.8.4640. PMID 9988700.
ncbi.nlm.nih.gov
- Human PubMed Reference:
- Mouse PubMed Reference:
- “A human Ro/SS-A autoantigen is the homologue of calreticulin and is highly homologous with onchocercal RAL-1 antigen and an aplysia "memory molecule"”. The Journal of Clinical Investigation 86 (1): 332–5. (Jul 1990). doi:10.1172/JCI114704. PMC 296725. PMID 2365822.
- “Entrez Gene: calreticulin”. 2023年1月28日閲覧。
- “HLA-H and associated proteins in patients with hemochromatosis”. Molecular Medicine (Cambridge, Mass.) 3 (6): 397–402. (June 1997). PMC 2230203. PMID 9234244.
- “Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2”. The New England Journal of Medicine 369 (25): 2391–405. (Dec 2013). doi:10.1056/NEJMoa1312542. PMC 3966280. PMID 24325359.
- “Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47”. Science Translational Medicine 2 (63): 63ra94. (Dec 2010). doi:10.1126/scitranslmed.3001375. PMC 4126904. PMID 21178137.
  - Christopher Vaughan (December 22, 2010). “Many cancer cells found to have an 'eat me' signal in study”. Stanford School of Medicine. 2013年10月16日時点のオリジナルよりアーカイブ。2023年1月29日
  pmc.ncbi.nlm.nih.gov
  - “A human Ro/SS-A autoantigen is the homologue of calreticulin and is highly homologous with onchocercal RAL-1 antigen and an aplysia "memory molecule"”. The Journal of Clinical Investigation 86 (1): 332–5. (Jul 1990). doi:10.1172/JCI114704. PMC 296725. PMID 2365822.
  - “HLA-H and associated proteins in patients with hemochromatosis”. Molecular Medicine (Cambridge, Mass.) 3 (6): 397–402. (June 1997). PMC 2230203. PMID 9234244.
  - Kozlov, Guennadi; Gehring, Kalle (2020-10). “Calnexin cycle - structural features of the ER chaperone system”. The FEBS journal 287 (20): 4322–4340. doi:10.1111/febs.15330. ISSN 1742-4658. PMC 7687155. PMID 32285592.
  - “Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2”. The New England Journal of Medicine 369 (25): 2391–405. (Dec 2013). doi:10.1056/NEJMoa1312542. PMC 3966280. PMID 24325359.
  - “Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47”. Science Translational Medicine 2 (63): 63ra94. (Dec 2010). doi:10.1126/scitranslmed.3001375. PMC 4126904. PMID 21178137.
    - Christopher Vaughan (December 22, 2010). “Many cancer cells found to have an 'eat me' signal in study”. Stanford School of Medicine. 2013年10月16日時点のオリジナルよりアーカイブ。2023年1月29日
    meshb.nlm.nih.gov
    - Mobilferrin - MeSH・アメリカ国立医学図書館・生命科学用語シソーラス（英語）

stanford.edu

med.stanford.edu

“Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47”. Science Translational Medicine 2 (63): 63ra94. (Dec 2010). doi:10.1126/scitranslmed.3001375. PMC 4126904. PMID 21178137.
- Christopher Vaughan (December 22, 2010). “Many cancer cells found to have an 'eat me' signal in study”. Stanford School of Medicine. 2013年10月16日時点のオリジナルよりアーカイブ。2023年1月29日

web.archive.org

“Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47”. Science Translational Medicine 2 (63): 63ra94. (Dec 2010). doi:10.1126/scitranslmed.3001375. PMC 4126904. PMID 21178137.
- Christopher Vaughan (December 22, 2010). “Many cancer cells found to have an 'eat me' signal in study”. Stanford School of Medicine. 2013年10月16日時点のオリジナルよりアーカイブ。2023年1月29日

wikipedia.org

en.wikipedia.org

GRCh38: Ensembl release 89: ENSG00000179218 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000003814 - Ensembl, May 2017

worldcat.org

search.worldcat.org

Kozlov, Guennadi; Gehring, Kalle (2020-10). “Calnexin cycle - structural features of the ER chaperone system”. The FEBS journal 287 (20): 4322–4340. doi:10.1111/febs.15330. ISSN 1742-4658. PMC 7687155. PMID 32285592.
Burns, K.; Duggan, B.; Atkinson, E. A.; Famulski, K. S.; Nemer, M.; Bleackley, R. C.; Michalak, M. (1994-02-03). “Modulation of gene expression by calreticulin binding to the glucocorticoid receptor”. Nature 367 (6462): 476–480. doi:10.1038/367476a0. ISSN 0028-0836. PMID 8107808.
Dedhar, S.; Rennie, P. S.; Shago, M.; Hagesteijn, C. Y.; Yang, H.; Filmus, J.; Hawley, R. G.; Bruchovsky, N. et al. (1994-02-03). “Inhibition of nuclear hormone receptor activity by calreticulin”. Nature 367 (6462): 480–483. doi:10.1038/367480a0. ISSN 0028-0836. PMID 8107809.
Orth, T.; Dorner, T.; Meyer Zum Buschenfelde, K. H.; Mayet, W. J. (1996-03). “Complete congenital heart block is associated with increased autoantibody titers against calreticulin”. European Journal of Clinical Investigation 26 (3): 205–215. doi:10.1046/j.1365-2362.1996.120270.x. ISSN 0014-2972. PMID 8904349.